XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 8,006 $ 5,927
Interest, accounts receivable and other receivables, net 5,611 5,788
Assets held for sale, net (Note 4) 6,488 6,398
Other current assets 1,088 2,141
Total current assets 21,193 20,254
Finance receivables, net of allowance for credit losses of $8,826 and $11,249 as of June 30, 2025 and December 31, 2024, respectively 237,604 277,760
Collateral on foreign currency forward contract 0 2,750
Marketable investments 603 580
Deferred tax assets, net 21,219 23,484
Warrant assets 4,612 4,366
Other non-current assets 466 3,041
Total assets 285,697 332,235
Current liabilities:    
Accounts payable and accrued liabilities 2,101 2,810
Liabilities held for sale (Note 4) 1,278 1,255
Deferred income 3,300 1,500
Total current liabilities 6,679 5,565
Unsecured senior notes, net 31,736 31,412
Revolving credit facility 294 6,233
Other non-current liabilities 519 335
Total liabilities 39,228 43,545
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,183,906 and 12,213,599 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 12 12
Additional paid-in capital 4,418,773 4,419,991
Accumulated deficit (4,172,316) (4,131,313)
Total stockholders' equity 246,469 288,690
Total liabilities and stockholders' equity $ 285,697 $ 332,235